Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes Mellitus
Status:
Terminated
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and effectiveness of multiple doses of
TAK-379, once daily (QD), in subjects with type 2 diabetes mellitus.